Six different production sites located in Italy, the USA and China, each one specialized in a specific step of the process, ensure a technologically advanced product portfolio. (Source: Ima)
Pharma Equipment

Vaccine Manufacturing Lines from a Single Source

The Covid-19 pandemic is far from over, and the threat of future pandemics created by novel viruses is very real. There is a growing need to supply a global market with innovative medicines at a profitable cost. So pharmaceutical equipment manufacturers have to react quickly, while maintaining due levels of diligence and social responsibility. To meet this demand, we at Ima Group operate in highly specialized pharmaceutical divisions, focusing on specific processing and packaging areas, in order to provide our customers real added value based on two main criteria.

Read on
Prof. Jakob Burger, TUM: “Compared to conventional technologies there is a price gap that must be closed. To do this, we either have to subsidise power-to-X products or make fossil ones more expensive.” (Source: Jan Troeschel/TUM)
Thermal Processing

OME Synthesis: A New Route to Diesel Fuels?

Power-to-X is on everyone’s lips: as energy storage, alternatives to battery-electric mobility or basic raw materials for industrial processes, the conversion of green electricity into material form is a cornerstone of all defossilization strategies. But how realistic is the vision of fuel from the socket? A test plant in Lower Bavaria, Germany, shows that the necessary technologies have long been in the starting blocks.

Read on
Continuous multi-purpose platform for the production of tablets from powders. (Source: Gea)
Continuous Production in the Pharmaceutical Industry

Why Will it No Longer be Possible to Work without Continuous Production?

Continuous production has arrived in the pharmaceutical manufacturing sector and it’s not going away anytime soon. Spurred on by the ever-increasing number of innovative and at the same time very expensive active ingredients, the pharmaceutical industry is relying on technology to reach the market faster and to ensure less wastage of expensive active ingredient used for clinical samples, scale up and release procedures. How are new drugs changing the rules of the game in production?

Read on
PROCESS regularly reports on the Chinese chemical and pharmaceutical market with the format 'China Market Insider'. (Source: ©sezerozger - stock.adobe.com)
China Market Insider

How AI is Revolutionizing the Pharmaceutical Industry in China

Artificial intelligence start-ups have begun to revolutionize the Chinese pharmaceutical industry. With the help of algorithms and ‘Big Data,’ the development time for new drugs is being radically reduced, in some cases from ten to 15 years to just one to one and a half years. The Chinese start-ups with the best prospects are currently being showered with billions of dollars in investment. The general technological trend fueling this development is called bio convergence.

Read on
Interview partner: Andreas Kaufmann, Head of Marketing and Innovation at R. Stahl. (Bild: R. Stahl)
Explosion Protection

The Future of Explosion Protection

Challenges for manufacturers of explosion protection solutions – LNG, hydrogen, and digitalization of process plants with Ethernet-APL are focal points for manufacturers of explosion protection solutions. We talked to Dr Andreas Kaufmann, Head of Marketing and Innovation at R. Stahl, about how the Ex specialist is dealing with these future challenges.

Read on
An automatic calibration autoregulation function has been introduced for Ima Active's new Domina tableting machine.  (Source:Ima Active)
Pharma Automation

How Autoregulation Function on a Tablet Press Works

The automation on a Domina tablet press is a step ahead of other machines as it helps to maximize production and minimize errors. The article elaborates on how Ima Active applies machine learning to set-up a machine automatically, allowing product quality and production efficiency to be of the highest standard and guaranteeing a quick return on customer investment.

Read on